
Study maps the influenza virus's takeover of human cells
New study reveals how flu virus hijacks human cells to multiply
Browse recent medication, recall, and health-related stories.
Page 40 of 51

New study reveals how flu virus hijacks human cells to multiply

By Nisha Rai, Dharan, July 20: Thirty five pharmacies operating in the premises of the BP Koirala Institute of Health Sc...

In a new study, brain scans reveal that frequent TV watching is linked to brain changes associated with memory decline.
Ongoing Xanamem (emestedastat) Alzheimer’s disease pivotal trial progresses toward final results in November this year

Emcure Pharmaceuticals expands the use of Poviztra, its GLP-1 drug semaglutide, to treat non-cirrhotic MASH, a progressive liver disease with limited options, following CDSCO approval for Wegovy.
Prayagraj Police destroy 1,115.95 kg seized cannabis worth Rs 5.58 crore under Operation Dahan, following NDPS procedures at an approved facility.

Merck’s Lipfendra is the first FDA-approved pill in the class of cholesterol-lowering drugs called PCSK9 inhibitors. While peptides are typically injected, Lipfendra is a macrocyclic peptide designed for formulation as an oral drug. The post Merck Pill Becomes First Oral Option in Growing Class of Cholesterol-Lowering Drugs appeared first on MedCity News .

When you go for a run, play a weekend football match, or lift weights at the gym, sweating

A pharmacist has spoken after news of an increase in infections
There is now better protection for brain health across the globe, so why do we understand less about dementia than ever?



Merck’s Lipfendra is the first FDA-approved pill in the class of cholesterol-lowering drugs called PCSK9 inhibitors. While peptides are typically injected, Lipfendra is a macrocyclic peptide designed for formulation as an oral drug. The post Merck Pill Becomes First Oral Option in Growing Class of Cholesterol-Lowering Drugs appeared first on MedCity News .

